Detalhe da pesquisa
1.
Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.
World J Urol
; 34(12): 1667-1672, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27106493
2.
Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia.
Br J Anaesth
; 125(5): e402-e404, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32703551
3.
Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma.
Eur Urol
; 84(2): 166-175, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085424
4.
Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy.
Eur Urol
; 81(6): 570-573, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35183395
5.
Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
Eur Urol Focus
; 8(5): 1278-1288, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288096
6.
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types.
Nat Biotechnol
; 40(4): 499-506, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725502
7.
Predictors of long-term renal function after kidney surgery for patients with preoperative chronic kidney disease.
Can Urol Assoc J
; 15(2): E103-E109, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744993